Soumya J Niranjan1, Michelle Y Martin2, Mona N Fouad3, Selwyn M Vickers4, Jennifer A Wenzel5, Elise D Cook6, Badrinath R Konety7, Raegan W Durant3. 1. Department of Health Services Administration, University of Alabama at Birmingham, Birmingham, Alabama. 2. Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, Tennessee. 3. Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama. 4. Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama. 5. Department of Acute and Chronic Care, Johns Hopkins University, Baltimore, Maryland. 6. Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas. 7. Department of Urology, University of Minnesota, Minneapolis, Minnesota.
Abstract
BACKGROUND: In recent years, extensive attention has been paid to the possibility that bias among health care professionals contributes to health disparities. In its 2003 report, the Institute of Medicine concluded that bias against racial minorities may affect communication or care offered. However, to the authors' knowledge, the role of bias within the context of recruitment of racial and ethnic minorities to cancer clinical trials has not been explored to date. Therefore, the authors assessed the experiences of clinical and research personnel related to factors influencing the recruitment of racial and ethnic minorities for cancer clinical trials. METHODS: A total of 91 qualitative interviews were conducted at 5 US cancer centers among 4 stakeholder groups: 1) cancer center leaders; 2) principal investigators; 3) referring clinicians; and 4) research staff. Data analysis was conducted using a content analysis approach to generate themes from the transcribed interviews. RESULTS: Five prominent themes emerged: 1) recruitment interactions with potential minority participants were perceived to be challenging; 2) potential minority participants were not perceived to be ideal study candidates; 3) a combination of clinic-level barriers and negative perceptions of minority study participants led to providers withholding clinical trial opportunities from potential minority participants; 4) when clinical trial recruitment practices were tailored to minority patients, addressing research misconceptions to build trust was a common strategy; 5) for some respondents, race was perceived as irrelevant when screening and recruiting potential minority participants for clinical trials. CONCLUSIONS: Not only did some respondents view racial and ethnic minorities as less promising participants, some respondents reported withholding trial opportunities from minorities based on these perceptions. Some providers endorsed using tailored recruitment strategies whereas others eschewed race as a factor in trial recruitment. The presence of bias and stereotyping among clinical and research professionals recruiting for cancer clinical trials should be considered when designing interventions to increase minority enrollment.
BACKGROUND: In recent years, extensive attention has been paid to the possibility that bias among health care professionals contributes to health disparities. In its 2003 report, the Institute of Medicine concluded that bias against racial minorities may affect communication or care offered. However, to the authors' knowledge, the role of bias within the context of recruitment of racial and ethnic minorities to cancer clinical trials has not been explored to date. Therefore, the authors assessed the experiences of clinical and research personnel related to factors influencing the recruitment of racial and ethnic minorities for cancer clinical trials. METHODS: A total of 91 qualitative interviews were conducted at 5 US cancer centers among 4 stakeholder groups: 1) cancer center leaders; 2) principal investigators; 3) referring clinicians; and 4) research staff. Data analysis was conducted using a content analysis approach to generate themes from the transcribed interviews. RESULTS: Five prominent themes emerged: 1) recruitment interactions with potential minority participants were perceived to be challenging; 2) potential minority participants were not perceived to be ideal study candidates; 3) a combination of clinic-level barriers and negative perceptions of minority study participants led to providers withholding clinical trial opportunities from potential minority participants; 4) when clinical trial recruitment practices were tailored to minority patients, addressing research misconceptions to build trust was a common strategy; 5) for some respondents, race was perceived as irrelevant when screening and recruiting potential minority participants for clinical trials. CONCLUSIONS: Not only did some respondents view racial and ethnic minorities as less promising participants, some respondents reported withholding trial opportunities from minorities based on these perceptions. Some providers endorsed using tailored recruitment strategies whereas others eschewed race as a factor in trial recruitment. The presence of bias and stereotyping among clinical and research professionals recruiting for cancer clinical trials should be considered when designing interventions to increase minority enrollment.
Authors: Erica K Barnell; Yiming Kang; Andrew R Barnell; Kimberly R Kruse; Jared Fiske; Zachary R Pittz; Adnan R Khan; Thomas A Huebner; Faith L Holmes; Malachi Griffith; Obi L Griffith; Aadel A Chaudhuri; Elizabeth M Wurtzler Journal: Clin Transl Gastroenterol Date: 2021-05-24 Impact factor: 4.488
Authors: Soumya J Niranjan; Jennifer A Wenzel; Michelle Y Martin; Mona N Fouad; Selwyn M Vickers; Badrinath R Konety; Raegan W Durant Journal: JCO Oncol Pract Date: 2021-05
Authors: Kacie D Deters; Valerio Napolioni; Reisa A Sperling; Michael D Greicius; Richard Mayeux; Timothy Hohman; Elizabeth C Mormino Journal: Neurology Date: 2021-02-10 Impact factor: 9.910
Authors: Ramy Sedhom; Richard Nudotor; Karen M Freund; Thomas J Smith; Lisa A Cooper; Jill T Owczarzak; Fabian M Johnston Journal: JCO Oncol Pract Date: 2021-01-21